Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,072 | 0 | 4 | N/A | N/A |
| Marketable Securities | 2,000 | N/A | N/A | N/A | N/A |
| Receivables | 251 | N/A | N/A | N/A | N/A |
| TOTAL | $47,130 | $0 | $4 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 76 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 131 | 0 | 0 | 0 | 0 |
| TOTAL | $207 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $47,336 | $0 | $4 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,027 | 24 | 26 | 0 | 0 |
| Accrued Expenses | 3,331 | N/A | N/A | N/A | N/A |
| TOTAL | $7,775 | $33 | $26 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 417 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,775 | $33 | $26 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,135 | 5,000 | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 1 | N/A | N/A |
| Retained earnings | -49,524 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 0 | -43 | -32 | 0 | 0 |
| TOTAL | $39,561 | $-33 | $-22 | $N/A | $N/A |
| Total Liabilities And Equity | $47,336 | $0 | $4 | $0 | $0 |